Back to Top Skip to main content Skip to sub-navigation

WRNMMC’s participation in APOLLO program furthers cancer research

Image of Two groups of vials on a table. Vials containing DNA samples from studies of the genetic risk for cancer at the Cancer Genomics Research Laboratory, part of the National Cancer Institute's Division of Cancer Epidemiology and Genetics. (Photo by Daniel Sone, National Cancer Institute.)

Recommended Content:

Research and Innovation | Health Readiness & Combat Support

As cancer survivors, oncologist, researchers, providers and family members celebrated World Cancer Day today, the researchers, providers and support staff at the John P. Murtha Cancer Center (MCC) at Walter Reed National Military Medical Center in Bethesda, Maryland remain focused on the studying not only the effects of the deadly disease, but also best possible treatment options.

The MCC serves as the preeminent cancer research and treatment facility within the Department of Defense, and has been since the 1990s. In 2012, the center was renamed after Congressman John P. Murtha, a 30 year Marine Corps veteran and long-time advocate for cancer research within the Department of Defense.

The current Director of MCC and its Research Program, Dr. Craig Shriver, is focused on the threat cancer poses on the readiness of the United States Armed Forces. According to Shriver, there are more than 1,000 active duty service members diagnoses with cancer each year, and there are more than 8,000 active duty service members living with a cancer diagnosis. Researchers at the MCC are keenly interested in how cancer affects younger people, since most active duty service members are under the age of 35, Shriver explained.

To combat the effect cancer has on the readiness of the DOD’s mission, MCC has done research into the genetic causes of cancer. According to Shriver, MCC centers have been sequencing the genome of tumors for different cancer since the 1990s. According to Shriver, since the DoD has a disproportionately high number of African American’s compared to the general U.S. population, sequencing of tumors from African Americans with prostate cancer has shown certain genetic risk factors that had not been found previously. “This is research that not only benefits African American service members, but people of African descent worldwide,” says Shriver.

Currently the MCC is using genetic sequencing as part of its participation in the APOLLO (Applied Proeogenomics Organizational Learning Outcomes) research program. According to the National Cancer Institutes’ webpage, APOLLO is part of the Cancer Moonshot initiative, a tri-federal research program that began in 2016 under the leadership of then Vice President Joe Biden. APOLLO brings together the DOD through MCC, the departments of Veterans Affairs; and the department of Health and Human Services through the NCI. According to Shriver the three agencies work together in sharing research and information, as well as publishing the results of the program.

A group of medical researchers in a line, sitting down in front of monitors
Researchers at the John P. Murtha Cancer Center at WRNMMC study the genetic makeup of cancer cells. As part of the APOLLO research program, the Murtha Cancer Center is undergoing studies related to the genetics found in the tumors of cancer patients. The genetic sequencing of these tumors is leading to new discoveries in the treatment of cancer within active duty service members in the DOD. (Photo courtesy of Walter Reed National Military Medical Center.)

APOLLO studies the genetic components of tumors from cancer patients. According to Shriver, every newly diagnoses cancer patient in on of the Murtha facilities are given the option to join the research program. If a patient opts in, their tumor is run through all available molecular platforms looking at its DNA, RNA, and Protein structure.

According to NCI, the data from the APOLLO program will be “curated and made available publicly through the Genomic Data CommonsProteomic Data Portal, and Cancer Imaging Archive.  Using all of the data available (analytical, invasive, noninvasive, and clinical) will enable researchers to study the relationships among these data, validate results, and develop predictive and prognostic models to improve patient care.”

According to Shriver APOLLO uses precision oncology where researchers look to see if there are any special molecular signatures of an individual’s cancer that be targeted with available drugs. Shriver says that tumors of the same cancer type can have different genetic attributes, which might require different treatments. “We don’t treat every patient with colon cancer the same. You identify any unique aspects of the tumor and say, ‘okay this tumor is special in this way, we identified it through the molecular signature found in the APOLLO program’, and we treat it that way,” said Shriver.

After sequencing the genetic makeup of their tumor, a patient’s blood is then sequenced to find the DNA unique to that person. According to Shriver, many young people with cancer have a genetic germline mutation that could cause cancer. And there are 50 different genes that can lead, in isolation or combined, to an increased risk of cancers.

The APOLLO program also shares any information from their research back with the patient. “We have a very unique, almost unprecedented, genetic return of results program,” Shriver said adding “If we identify that service member X has a germline genetic mutation that could affect them, and their children, for increased cancer risk, we tell the patient that. This is unusual for a research program.”

Shriver says that this information sharing is called translational research. The gap between clinical care and research is translated and provides real benefits to patients and their providers through the genome sequencing of the patient’s blood.

The research from the APOLLO program is already starting to have real benefits to not only the DOD, but the United States population at large. According to Shriver, researchers in the program identified a new genetic signature that can distinguish between patients with lung cancer who will do well with a specific treatment from those who may not do well with said treatment. “If 20% of the population don’t do well for conventional treatment, and by sequencing the genetic of the tumor, we can find those patients and move forward with more unique options,” said Shriver.

The signature is intellectual property, and as such a patent is being filed so that it can be commercialized, and a test can go to the market. Lung cancer patients can take the panel test and providers can predict if they will do well with treatment or should try something else.

While the APOLLO program is beneficial for a more hidden side of the causes of cancer, Shriver still encourages known preventative measure should be taken by all active duty service members. Shriver says that avoiding or quitting use of tobacco and nicotine products are a good common knowledge practice.

According to Director of Gynecologic Oncology at WRNMMC, Air Force Col. (Dr.) Yovanni Casablanca, all service members regardless of gender should get the human papilloma virus, or HPV, vaccine which protects against cervical cancer.

Shriver believes genetic sequencing can be helpful to the DOD’s mission in the future outside of cancer research. According to Shriver, genetic sequencing could be utilized at military intake alongside other medical tests, to determine an individual’s genetic risk to certain cancers. “This wouldn’t be us turning someone away based on their sequencing. Instead we can use this information to help a service member who may be higher risk be aware and take proactive steps to mitigate the potential onset of certain cancers,” said Shriver.

For more information about the Murtha Cancer Center, or the APOLLO program, check their websites.

You also may be interested in...

The New Public Health Director Talks about His Goals for Force Readiness

Article
4/5/2022
Rear Admiral Brandon Taylor of the U.S. Public Health Service Commissioned Corps in dress whites at the 2019 National Independence Day Parade where he represented the U.S. Surgeon General as a presiding official with the other services. Taylor was named in February as the new director of the Defense Health Agency’s Public Health directorate. (Photo: Tanisha Blaise, Armed Forces Health Surveillance Division senior public relations and media specialist)

Rear Adm. Brandon Taylor was recently appointed to be the new director for the Defense Health Agency’s Public Health directorate. In an interview, he discussed how he is approaching his new role, his goals for Public Health within DHA, and the importance of Public Health to a medically ready force and a ready medical force.

Recommended Content:

Public Health | Health Readiness & Combat Support | Military Health System Transformation

MSMR Vol. 29 No. 04 - April 2022

Report
4/1/2022

A monthly publication of the Armed Forces Health Surveillance Division. This issue of the peer-reviewed journal contains the following articles: Exertional heat illness at Fort Benning, GA: Unique insights from the Army Heat Center; Update: Heat illness, active component, U.S. Armed Forces, 2021; Update: Exertional rhabdomyolysis, active component, U.S. Armed Forces, 2017–2021; Update: Exertional hyponatremia, active component, U.S. Armed Forces, 2006–2021

Recommended Content:

Health Readiness & Combat Support | Public Health

Military Health System Research Program Notice of Funding Opportunity

Fact Sheet
3/31/2022

This flyer describes the process for applying for and receiving funding by the Military Health System Research Program.

Recommended Content:

Military Health System Research Branch | Research and Innovation

How COVID-19 Made the Military Medical Community Stronger

Article
3/21/2022
Image of a service member being treated

Lessons learned from the COVID-19 pandemic has made the military medical community stronger and will help when confronting the next crisis, whether that’s another pandemic, a new conflict or natural disaster

Recommended Content:

Health Readiness & Combat Support | Coronavirus and the COVID-19 Vaccine | Coronavirus

Top Military Health Leaders Discuss Future Readiness

Article
3/8/2022
An Air Force C-17 Globemaster III at Joint Base Pearl Harbor-Hickam, Hawaii, prepares to transport U.S. Army medical personnel to Guam in support of the global COVID-19 response on April 13, 2020.

Top military health leaders highlight the importance of preparing for the future to ensure both a medically ready force and a ready medical force.

Recommended Content:

Health Readiness & Combat Support

MSMR Vol. 29 No. 03 - March 2022

Report
3/1/2022

A monthly publication of the Armed Forces Health Surveillance Division. This issue of the peer-reviewed journal contains the following articles: Update: Malaria, U.S. Armed Forces, 2021; Obesity prevalence among active component service members prior to and during the COVID-19 pandemic, January 2018–July 2021; Brief report: Refractive surgery trends at tri-service refractive surgery centers and the impact of the COVID-19 pandemic, fiscal years 2000–2020; Brief report: Using syndromic surveillance to monitor MIS-C associated with COVID-19 in Military Health System beneficiaries; Surveillance snapshot: Medical separation from service among incident cases of osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Recommended Content:

Health Readiness & Combat Support | Public Health

The Chief of the Army Dental Corps Talks Dental Health & Readiness

Article
2/22/2022
The Army’s top dentist talks about what service members should keep in mind about their dental health.

Here’s what the Army’s top dentist thinks service members should keep in mind about their dental health.

Recommended Content:

Health Readiness & Combat Support | Total Force Fitness | TRICARE Dental Care

MSMR Vol. 29 No. 02 - February 2022

Report
2/1/2022

A monthly publication of the Armed Forces Health Surveillance Division. This issue of the peer-reviewed journal contains the following articles: Diagnosis of hepatitis C infection and cascade of care in the active component, U.S. Armed Forces, 2020; A new approach to categorization of ocular injury among U.S. Armed Forces; Surveillance snapshot: Health care burden attributable to osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Recommended Content:

Health Readiness & Combat Support | Public Health

Campaign Plan Targets Medical Readiness, Better Health

Article
1/26/2022
(From left) Army Lt. Col. Shimul Patel, chief, Plastic Surgery Services, Landstuhl Regional Medical Center, and U.S. Army Lt. Col. Jessica Peck, chief, Ear, Nose and Throat Clinic, LRMC, operate on a cancer patient during the first microvascular reconstruction and anastomosis procedure ever performed at LRMC, Dec. 3, 2021.

DHA’s five-year plan focused on improving global health care delivery, military readiness.

Recommended Content:

Ready Reliable Care | Health Readiness & Combat Support

Researchers Connect with Warfighters to Guide Tech Development

Article
1/25/2022
Military personnel trying an immersive training device

Researchers ‘get out of the clinic’ to learn warfighter challenges

Recommended Content:

Research and Innovation | Vision and Hearing Loss Prevention | Vision and Hearing Loss Prevention | Vision Center of Excellence

The British 'Limeys' Were Right: A Short History of Scurvy

Article
1/10/2022
Scurvy, a disease caused by lack of vitamin C, sickened sailors who had no access to fresh food supplies, and killed more than 2 million sailors between the 16th and 18th centuries alone.

How citrus fruits quelled the scourge of scurvy.

Recommended Content:

Health Readiness & Combat Support | Nutritional Fitness | Our History

2022 MHS Research Symposium Opens for 'Abstracts'

Article
1/6/2022
Poster of the MHSRS 2022

Abstracts for this year's Military Health System Research Symposium, with the theme "Optimizing Readiness – The Power of Military Medical Research," are due by Feb. 16.

Recommended Content:

Research and Innovation | Medical Research and Development | MHS Research Symposium

MSMR Vol. 29 No. 01 - January 2022

Report
1/1/2022

A monthly publication of the Armed Forces Health Surveillance Division. This issue of the peer-reviewed journal contains the following articles: Description of a COVID-19 Beta variant outbreak, Joint Base Lewis-McChord, WA, February–March 2021; COVID-19 and depressive symptoms among active component U.S. service members, January 2019–July 2021; Surveillance snapshot: Lengths of hospital stays for service members diagnosed with sepsis, active component, U.S. Armed Forces, 2011–2020.

Recommended Content:

Health Readiness & Combat Support | Public Health

Hearing Problems Decline

Photo
12/14/2021
Hearing Problems Decline

Hearing loss in the Department of Defense continues to decrease for service members and civilians enrolled in hearing conservation programs.

Recommended Content:

Health Readiness & Combat Support | Conditions and Treatments

Meet the First Coast Guard Sponsored USU Medical Student

Article
12/9/2021
US Coast Guard Ensign Bobczynski smiles at camera

U.S. Coast Guard Academy graduate Ensign Elyse Bobczynski is the first USCG-sponsored student to attend medical school at the Uniformed Services University.

Recommended Content:

Health Readiness & Combat Support | Uniformed Services University of the Health Sciences
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 45
Refine your search
Last Updated: February 04, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.